• Listen: Moderna v. NIH, psilocybin as a medicine, & the cultural intake of pharma CEOs

    17 days ago - By STAT

    Who invented Moderna's Covid-19 vaccine? Can psychedelic medicines be mainstream? And who's going to run the FDA?
    We cover all that and more this week on “The Readout LOUD,” STAT's biotech podcast. Rebecca Robbins of the New York Times joins us to discuss the escalating tension between Moderna and the National Institutes of Health over just who invented a Covid-19 vaccine. Then, STAT's Olivia Goldhill calls in to explain Compass Pathways' promising results using psilocybin as a treatment for depression and the future of the nascent field of psychedelic medicines. We also discuss the latest...
    Read more ...

     

  • STAT+: ‘A work in progress': BioNTech's CEO wants to widen Covid-19 vaccine access on his own terms

    17 days ago - By STAT

    Two years ago, Ugur Sahin was an under-the-radar but extremely determined scientist running a company called BioNTech, which was trying to generate interest in using mRNA technology to combat different illnesses. Since then, he partnered with Pfizer to develop a Covid-19 vaccine that this year is forecast to generate about $19 billion in revenue for the company, assuming 2.5 billion doses are shipped. The vaccine is an historic success story - scientifically, medically, and financially - for both companies.
    But there are also questions about the extent to which booster doses will - or...
    Read more ...